Search research articles
Contact Us
Filters
Showing results (881-890 of 903) with videos related to
Page
of 91
Sort By:
Obstetrics and Gynecology
|
January 8, 2021
Prophylactic Negative Pressure Wound Therapy After Laparotomy for Gynecologic Surgery: A Randomized Controlled Trial
Mario M Leitao, Qin C Zhou, Maria B Schiavone, et al.
Gynecologic Oncology
|
August 14, 2025
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
Tiffany Y Sia, Sara Moufarrij, Juliet Milani, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Tracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2024
Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNA
Marc J Williams, Ignacio Vázquez-García, Grittney Tam, et al.
Nature
|
October 1, 2025
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA
Marc J Williams, Ignacio Vázquez-García, Grittney Tam, et al.
Gynecologic Oncology
|
December 2, 2023
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
Ryan M Kahn, Pier Selenica, Thomas Boerner, et al.
Gynecologic Oncology
|
May 7, 2023
Germline drivers of gynecologic carcinosarcomas
Tiffany Y Sia, Sushmita B Gordhandas, Ozge Birsoy, et al.
Nature Communications
|
March 29, 2024
Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants
Tikvah K Hayes, Elisa Aquilanti, Nicole S Persky, et al.
Journal of Neuro-Oncology
|
August 29, 2019
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201
Andrew S Chi, Rohinton S Tarapore, Matthew D Hall, et al.
Cancer Cell
|
December 19, 2015
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
Kensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, et al.
Page
of 91
Search research articles
Search
Showing results (881-890 of 903) with videos related to
Sort By:
Page
of 91
Obstetrics and Gynecology
|
January 8, 2021
Prophylactic Negative Pressure Wound Therapy After Laparotomy for Gynecologic Surgery: A Randomized Controlled Trial
Mario M Leitao, Qin C Zhou, Maria B Schiavone, et al.
Gynecologic Oncology
|
August 14, 2025
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
Tiffany Y Sia, Sara Moufarrij, Juliet Milani, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Tracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2024
Tracking clonal evolution of drug resistance in ovarian cancer patients by exploiting structural variants in cfDNA
Marc J Williams, Ignacio Vázquez-García, Grittney Tam, et al.
Nature
|
October 1, 2025
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA
Marc J Williams, Ignacio Vázquez-García, Grittney Tam, et al.
Gynecologic Oncology
|
December 2, 2023
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival
Ryan M Kahn, Pier Selenica, Thomas Boerner, et al.
Gynecologic Oncology
|
May 7, 2023
Germline drivers of gynecologic carcinosarcomas
Tiffany Y Sia, Sushmita B Gordhandas, Ozge Birsoy, et al.
Nature Communications
|
March 29, 2024
Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants
Tikvah K Hayes, Elisa Aquilanti, Nicole S Persky, et al.
Journal of Neuro-Oncology
|
August 29, 2019
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201
Andrew S Chi, Rohinton S Tarapore, Matthew D Hall, et al.
Cancer Cell
|
December 19, 2015
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
Kensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, et al.
Page
of 91